William T Harris

Summary

Affiliation: University of Alabama at Birmingham
Country: USA

Publications

  1. ncbi Transforming growth factor-beta(1) in bronchoalveolar lavage fluid from children with cystic fibrosis
    William T Harris
    Division of Pulmonology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Pediatr Pulmonol 44:1057-64. 2009
  2. ncbi Plasma TGF-β₁ in pediatric cystic fibrosis: potential biomarker of lung disease and response to therapy
    William T Harris
    Division of Pulmonology, Department of Pediatrics, University of Alabama at Birmingham, 1600 7th Avenue South, Birmingham, AL 35233 1711, USA
    Pediatr Pulmonol 46:688-95. 2011
  3. ncbi Association of lower airway inflammation with physiologic findings in young children with cystic fibrosis
    Stacey L Peterson-Carmichael
    Division of Pulmonology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Pediatr Pulmonol 44:503-11. 2009
  4. ncbi Inhaled versus systemic antibiotics and airway inflammation in children with cystic fibrosis and Pseudomonas
    Terry L Noah
    Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7127, USA
    Pediatr Pulmonol 45:281-90. 2010
  5. ncbi Physiologic, bronchoscopic, and bronchoalveolar lavage fluid findings in young children with recurrent wheeze and cough
    John Saito
    Division of Pulmonology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7220, USA
    Pediatr Pulmonol 41:709-19. 2006

Collaborators

Detail Information

Publications5

  1. ncbi Transforming growth factor-beta(1) in bronchoalveolar lavage fluid from children with cystic fibrosis
    William T Harris
    Division of Pulmonology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Pediatr Pulmonol 44:1057-64. 2009
    ..However, few data link TGF-beta(1) protein levels and clinical markers of CF lung disease severity...
  2. ncbi Plasma TGF-β₁ in pediatric cystic fibrosis: potential biomarker of lung disease and response to therapy
    William T Harris
    Division of Pulmonology, Department of Pediatrics, University of Alabama at Birmingham, 1600 7th Avenue South, Birmingham, AL 35233 1711, USA
    Pediatr Pulmonol 46:688-95. 2011
    ..Initial steps in the investigation of the relationship between TGF-β₁ and CF lung disease include determining the most appropriate available biospecimen for TGF-β₁ protein measurement...
  3. ncbi Association of lower airway inflammation with physiologic findings in young children with cystic fibrosis
    Stacey L Peterson-Carmichael
    Division of Pulmonology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Pediatr Pulmonol 44:503-11. 2009
    ....
  4. ncbi Inhaled versus systemic antibiotics and airway inflammation in children with cystic fibrosis and Pseudomonas
    Terry L Noah
    Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7127, USA
    Pediatr Pulmonol 45:281-90. 2010
    ..Inhaled tobramycin has been shown to transiently clear Pseudomonas from lower airways in early cystic fibrosis (CF), but does not markedly reduce lung inflammation, a key factor in disease progression...
  5. ncbi Physiologic, bronchoscopic, and bronchoalveolar lavage fluid findings in young children with recurrent wheeze and cough
    John Saito
    Division of Pulmonology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7220, USA
    Pediatr Pulmonol 41:709-19. 2006
    ....